SVB Securities analyst Mani Foroohar downgraded Moderna to Underperform from Market Perform with a $93 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MRNA:
SVB Securities analyst Mani Foroohar downgraded Moderna to Underperform from Market Perform with a $93 price target.
Published first on TheFly
See today’s best-performing stocks on TipRanks >>
Read More on MRNA: